COA Fellows Initiative
The COA Fellows Initiative seeks to engage and educate oncology/hematology fellows on the value of practicing in the community setting. As fellows begin to make decisions about where to practice, the initiative is designed to explore, in detail, the opportunities community oncology presents.
Community oncology practices enable cancer patients to receive quality, affordable care in their own community. This is why the majority of Americans battling cancer choose to be treated in the community setting. However, recent estimates have shown that the country is facing a shortage of as many as 3,800 oncologists. At the same time, with the aging population and growing number of survivors due to the increased efficacy of cancer treatment, there will be a significant increase in the need for oncology services.
As physicians complete their three-year oncology and/or hematology fellowship, they have a choice of how and where they will practice. Unfortunately, the community setting is frequently overlooked as a career option by oncology/hematology fellows. The COA Fellows Initiative seeks to change this by educating fellows on present practice options and discuss the many factors to consider when making those decisions.
How Do I Get Involved?
Becoming a member of the COA Fellows Initiative is free and exclusively available to fellows interested in pursuing community oncology practices.
Advisory Board
Richard L. Martin III, MD, MPH
Tennessee Oncology
Tennessee Oncology Nashville, TN
Ted Arrowsmith, MD
Tennessee Oncology
Chattanooga, TN
Miriam J. Atkins, MD, FACP
AO Multispecialty Clinic
Augusta, GA
Davey Daniel, MD
Tennessee Oncology
Chattanooga, TN
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute
Hot Springs, AR
David Eagle, MD
New York Cancer & Blood Specialists
Patchogue, NY
Bobby Green, MD
Thyme Care
Nashville, TN
Richard Ingram, MD
Shenandoah Oncology
Winchester, VA
Edward Licitra, MD, PhD
Astera Health Partners/Astera Cancer Care
East Brunswick, NJ
Joseph Lynch, MD
Geisinger Medical Center
Danville, PA
Rick McDonough, MD
Florida Cancer Specialists & Research Institute
Land O’ Lakes, FL
Michael Diaz, MD
Florida Cancer Specialists & Research Institute
St. Petersburg, FL
Debra Patt, MD, PhD, MBA, FASCO
Texas Oncology
Austin, TX
Stephen Schleicher, MD, MBA
Tennessee Oncology
Nashville, TN
Fred Schnell, MD, FACP
Community Oncology Alliance; National Cancer Treatment Alliance; Cancer Center Of Middle Georgia
Warner Robins, GA
Mark Thompson, MD
Community Oncology Alliance
Washington, DC
Emily Touloukian, DO
Coastal Cancer Center
Myrtle Beach, SC
Harsha Vyas, MD, FACP
Cancer Center of Middle Georgia
Dublin, GA
Advisory Board
Richard L. Martin III, MD, MPH
Tennessee Oncology
Tennessee Oncology Nashville, TN
Ted Arrowsmith, MD
Tennessee Oncology
Chattanooga, TN
Miriam J. Atkins, MD, FACP
AO Multispecialty Clinic
Augusta, GA
Davey Daniel, MD
Tennessee Oncology
Chattanooga, TN
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute
Hot Springs, AR
David Eagle, MD
New York Cancer & Blood Specialists
Patchogue, NY
Bobby Green, MD
Thyme Care
Nashville, TN
Richard Ingram, MD
Shenandoah Oncology
Winchester, VA
Edward Licitra, MD, PhD
Astera Health Partners/Astera Cancer Care
East Brunswick, NJ
Joseph Lynch, MD
Geisinger Medical Center
Danville, PA
Rick McDonough, MD
Florida Cancer Specialists & Research Institute
Land O’ Lakes, FL
Michael Diaz, MD
Florida Cancer Specialists & Research Institute
St. Petersburg, FL
Debra Patt, MD, PhD, MBA, FASCO
Texas Oncology
Austin, TX
Stephen Schleicher, MD, MBA
Tennessee Oncology
Nashville, TN
Fred Schnell, MD, FACP
Community Oncology Alliance; National Cancer Treatment Alliance; Cancer Center Of Middle Georgia
Warner Robins, GA
Mark Thompson, MD
Community Oncology Alliance
Washington, DC
Emily Touloukian, DO
Coastal Cancer Center
Myrtle Beach, SC
Harsha Vyas, MD, FACP
Cancer Center of Middle Georgia
Dublin, GA